FDx Advisors’s Astera Labs ALAB Stock Holding History

FDx Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$714K	Sell	1,479 -660	-31%	-$175K	0.22%	75
2026 Q1	$234K	Buy	+2,139	New	+$305K	0.07%	162
2025 Q4	–	Sell	-1,476	Closed	-$276K	–	186
2025 Q3	$276K	Buy	+1,476	New	+$243K	0.08%	140

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FDx Advisors's ALAB Position: Q2 2026 in Review

FDx Advisors reduced its Astera Labs (ALAB) stake by 31% in Q2 2026, selling an estimated $175K and leaving 1,479 shares worth $714K. The position accounts for 0.22% of the portfolio, ranked #75.

FDx Advisors first reported a position in ALAB in Q3 2025 and has held it in 3 quarters since. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

FDx Advisors held 1,479 shares of Astera Labs worth $714K as of Q2 2026.
FDx Advisors sold 660 Astera Labs shares in Q2 2026, an estimated $175K.
Astera Labs made up 0.22% of FDx Advisors's portfolio in Q2 2026, its #75 holding.
FDx Advisors first reported a position in Astera Labs in Q3 2025 and has held it in 3 quarters since.
991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on FDx Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.